Cited by 571Bacterial Infections and VaccinesMicrobial infections and disease researchNeonatal and Maternal Infections

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, Caroline L, Andrews, Nick J, Kaczmarski, Edward B, Miller, Elizabeth, Ramsay, Mary E·2004·The Lancet

Open this paper in CoChat — free account

Abstract

The meningococcal serogroup C conjugate (MCC) vaccine programme in England has successfully controlled the incidence of serogroup C disease, as a result of high short-term vaccine effectiveness and substantial herd immunity. However, the long-term effectiveness of the vaccine remains unknown. We assessed surveillance data from the 4 years since introduction of the programme. Vaccine effectiveness remained high in children vaccinated in the catch-up campaign (aged 5 months to 18 years). However, for children vaccinated in the routine infant immunisation programme, the effectiveness of the MCC vaccine fell to low levels after only 1 year. The number of individuals in these cohorts remains low, but alternative routine immunisation schedules should be considered to ensure high levels of protection are sustained.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)16725-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
Miller, E. J., SALISBURY, D. M., & Ramsay, M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00299-7 · Cited by 483
Self-citation
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
Ramsay, M. E., Andrews, N. J., Trotter, C. L., Kaczmarski, E. B., & Miller, E. (2003) · BMJ · doi:10.1136/bmj.326.7385.365 · Cited by 409
Self-citation
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
Ramsay, M. E., Andrews, N. J., Kaczmarski, E. B., & Miller, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03594-7 · Cited by 337
Self-citation
Estimating Haemophilus influenzae Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method
Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172
Self-citation
Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom
Borrow, R., Goldblatt, D., Andrews, N. J., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K. A. V., & Miller, E. (2002) · The Journal of Infectious Diseases · doi:10.1086/344324 · Cited by 114
Self-citation

Show all 5 references

Research works printed but not linked: 1

Quarterly Communicable Disease Reports on the COVER programme for childhood immunisation

Sorted by citations

Items 401–500 of 571

Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
Tzanakaki, G., Cabrnochová, H., Delić, S., Drăgănescu, A. C., Hilfanova, A., Ónozó, B., Pokorn, M., Skoczyńska, A., & Tešović, G. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2301186 · Cited by 7
Defining efficacy in meningococcal vaccine trials
Keiser, P. B., & Gill, C. J. (2012) · Clinical Investigation · doi:10.4155/cli.12.52 · Cited by 7
Implementation and impact of a meningococcal C conjugate vaccination program in 13- to 25-year-old individuals in Galicia, Spain
Romero, E. R., Nartallo‐Penas, V., Rodríguez, J. A. T., Pintos, A. M., Vidal, X. H., & Pimentel, M. J. L. (2011) · Journal of Public Health · doi:10.1007/s10389-011-0403-9 · Cited by 7
Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada
Huang, L., Mauskopf, J., Farkouh, R., & Masaquel, C. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1878030 · Cited by 7
Group B meningococcal vaccine science and policy
Drysdale, S. B., & Pollard, A. J. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.04.021 · Cited by 7
Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis serogroup C diseases
Saydam, M., Burkin, K., Care, R. S., Rigsby, P., Bolgiano, B., & Mawas, F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.005 · Cited by 7
Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines
Wysocki, J., Tansey, S. P., Brachet, E., Baker, S., Gruber, W. C., Giardina, P. C., & Arora, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.047 · Cited by 7
The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment
Maiden, M. C. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03151 · Cited by 7
The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta
Pace, D., Gauci, C., & Barbara, C. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03914-8 · Cited by 7
Primary vaccination with a new heptavalent DTPw–HBV/Hib–Neisseria meningitidis serogroups A and C combined vaccine is well tolerated
Kerdpanich, A., Warachit, B., Kosuwon, P., GATCHALIAN, S. R., Watanaveeradej, V., Borkird, T., Kosalaraksa, P., Han, H.-H., Hutagalung, Y., Boutriau, D., et al. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2007.06.002 · Cited by 7
Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier
PÃ©rez, A. E., Dickinson, F., Banderas, F., Serrano, T., Llanes, R., Guzmán, D., DÃaz, P., Álvarez, A., Guirola, M., Caballero, E., et al. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00047.x · Cited by 7
New combination vaccines still need a boost
Pollard, A. J. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2006.106724 · Cited by 7
Evaluating Sistema Scotland: Initial Findings Report
Garnham, L. M., Campbell, A., Harkins, C., Tannahill, C., Kelly, L., Crossland, J., Watson, P., Maxwell, S., Halawi, J., Urquart, A., et al. (2015) · ResearchOnline · Cited by 7
Vaccins anti-méningococciques: Des vaccins polysaccharidiques aux vaccins conjugués
Cohen, R., & Lévy, C. (2012) · Archives de Pédiatrie · doi:10.1016/s0929-693x(12)71275-7 · Cited by 6
Risk Analysis by Age on the Burden of Meningococcal Disease in Spain
Calle, I. R., Raguindin, P. F., Pardo‐Seco, J., & Martinón‐Torres, F. (2022) · Vaccines · doi:10.3390/vaccines10040592 · Cited by 6
Novel Quadrivalent Meningococcal A, C, W-135 and Y Glycoconjugate Vaccine for the Broader Protection of Adolescents and Adults
Pace, D. (2010) · Future Microbiology · doi:10.2217/fmb.10.137 · Cited by 6
Estimating the Population-Level Effectiveness of Vaccination Programs in the Netherlands
van Wijhe, M., McDonald, S., de Melker, H. E., Postma, M. J., & Wallinga, J. (2017) · Epidemiology · doi:10.1097/ede.0000000000000778 · Cited by 6
Glycoconjugate Vaccines: The Clinical Journey
Lockhart, S. P., Scott, D. A., Jansen, K. U., Anderson, A. S., & Gruber, W. C. (2018) · ACS symposium series · doi:10.1021/bk-2018-1290.ch002 · Cited by 6
Neisseria meningitidis
Rouphael, N., Zimmer, S. M., & Stephens, D. S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369408-9.00053-6 · Cited by 6
From genomics to surveillance, prevention and control: New challenges for the African meningitis belt
Alonso, J., Bertherat, E., Perea, W., Borrow, R., Chanteau, S., Cohet, C., Dodet, B., Greenwood, B. M., LaForce, F. M., Rouzic, E. M., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.037 · Cited by 6
Reduction in invasive meningococcal disease in Queensland: A success for immunisation
Slinko, V. G., & Sweeny, A. L. (2007) · Communicable Diseases Intelligence · doi:10.33321/cdi.2007.31.21 · Cited by 6
Neisseria meningitidis
Pollard, A. J., & Finn, A. H. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00125-0 · Cited by 6
Neisseria meningitidis
Pollard, A. J., & Finn, A. H. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00127-6 · Cited by 6
Herpes Zoster Vaccine and the Medicare Population
BLACK, S. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw858 · Cited by 6
Human Infant Memory B Cell and CD4+ T Cell Responses to HibMenCY-TT Glyco-Conjugate Vaccine
Fuery, A., Richmond, P., & Currie, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133126 · Cited by 5
Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali
Basta, N. E., Borrow, R., Berthe, A., Traore, A., Onwuchekwa, U., Townsend, K., Boukary, R. M., Mabey, L., Findlow, H., Bai, X., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ602 · Cited by 5
Meningococcal Vaccination in the United States: Past, Present, And Future
Schillie, S. F., & McNamara, L. A. (2025) · Pediatric Drugs · doi:10.1007/s40272-024-00666-2 · Cited by 5
Phase II Study of a Three-dose Primary Vaccination Course of DTPa-IPV/Hib-MenC-TT Followed by a 12-month Hib-MenC-TT Booster in Healthy Infants
Khatami, A., Snape, M. D., Ohene-Kena, B., Young, K. K., Oeser, C., Michaelis, L. J., Macleod, E., Smee, H., Meeren, O. V. D., Leyssen, M., et al. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31828672a7 · Cited by 5
Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
Wing, J. B., Smart, L. E., Borrow, R., Findlow, J., Findlow, H., Lees, A., Read, R. C., & Heath, A. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031160 · Cited by 5
Meningococcal disease serogroup C
Dickinson, F., Cuevas, & Pérez, A. E. (2012) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s12711 · Cited by 5
Community cluster of meningococcal disease by Neisseria meningitidis serogroup C in Andalusia, Spain, March to May 2011
Cortés, J. M. M., Butrón, E. T., Fernández, M. G., Herrador, Z., Osakar, S. H., Luque, R. S., Morilla, E. P., & Enríquez, J. G. (2012) · Eurosurveillance · doi:10.2807/ese.17.36.20261-en · Cited by 5
Vaccines for international travel
Barnett, E. D., Kozarsky, P. E., & Steffen, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00065-3 · Cited by 5
Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt
Jackson, M. L., Diallo, A. O., Médah, I., Bicaba, B. W., Yaméogo, I., Koussoubé, D., Ouédraogo, R., Sangaré, L., & Mbaeyi, S. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206117 · Cited by 5
Development and evaluation of a rapid multianalyte particle-based flow cytometric assay for the quantification of meningococcal serogroup B-specific IgM antibodies in sera for nonculture case confirmation
Laher, G., Balmer, P., Gray, S. J., Dawson, M. M., Kaczmarski, E. B., & Borrow, R. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00121.x · Cited by 5
Self-citation
Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia
Backhouse, J. L., Gidding, H. F., MacIntyre, C. R., McIntyre, P. B., & Gilbert, G. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.087 · Cited by 5
Current concepts in the treatment of bacterial meningitis beyond the neonatal period
Clarke, E. T., & Heyderman, R. S. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.4.663 · Cited by 5
Enfermedad meningocócica e impacto de la vacunación sistemática con la vacuna conjugada antimeningocócia C en un área sanitaria de Andalucía
Rojo, C. C., Gil, C. G., Vera, J. N., & Morcillo, A. M. (2005) · Revista Española de Salud Pública · doi:10.1590/s1135-57272005000600005 · Cited by 4
Vaccine Immunology
Siegrist, C., & Eberhardt, C. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00002-5 · Cited by 4
Épidémiologie nouvelle des méningites bactériennes sous l’effet des vaccinations
Lévy, C., Varon, E., Bingen, É., Aujard, Y., BOUCHERAT, M., & Cohen, R. (2011) · Archives de Pédiatrie · doi:10.1016/s0929-693x(11)70982-4 · Cited by 4
Antibiotic Resistance in Neisseria
Bash, M. C., McKnew, D. L., & TAPSALL, J. W. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_6 · Cited by 4
Carbohydrate-based anti-bacterial and anti-cancer vaccines
Das, R., & Mukhopadhyay, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816675-8.00014-2 · Cited by 4
Immunogenicity and Reactogenicity of Pneumococcal Conjugate Vaccines in Infants and Children
Käyhty, H. M., Lockhart, S. P., & Schuerman, L. (2014) · ASM Press eBooks · doi:10.1128/9781555815820.ch16 · Cited by 4
Vaccine Failure After Meningococcal C Conjugate Vaccine May Be Linked to Decline of Bactericidal Titers and Absence of Herd Immunity
Matar, R., Hong, E., Lévy, C., Guillot, M., Cohen, R., Taha, M., & Madhi, F. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000833 · Cited by 4
Surveillance of bacterial meningitis in an Angolan pediatric hospital after the introduction of pneumococcal conjugate vaccines
Urtti, S., Cruzeiro, M. L., de Gouveia, L., Peltola, H., von Gottberg, A., Kyaw, M. H., & Pelkonen, T. (2019) · Journal of Global Health Reports · doi:10.29392/joghr.3.e2019091 · Cited by 4
Vaccine coverage estimation using a computerized vaccination registry with potential underreporting and a seroprevalence study
Pérez–Breva, L., Díez‐Domingo, J., Martínez‐Beneito, M. A., & Puig‐Barberà, J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.048 · Cited by 4
Prevention of Invasive Meningococcal Disease in the United States
Pelton, S. I. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a2d6b5 · Cited by 4
Meninigitis immunisation: challenges, successes and new developments
Boulton, J. (2013) · British Journal of Nursing · doi:10.12968/bjon.2013.22.1.20 · Cited by 4
Entrepreneurship and Global Health: Catalyzing the EcosystemPreprint
Li, J., & Garnsey, E. W. (2011) · SSRN Electronic Journal · doi:10.17863/cam.44072 · Cited by 4
Unterschiedliche Impfschemata in Europa
Wiedermann, U. (2009) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-009-1974-1 · Cited by 3
Immunoglobulin G Avidities in Infants in Mexico after Primary Immunization with Three Doses of Polyribosylribitol Phosphate-Tetanus ToxoidHaemophilus influenzaeType b Vaccine
de León, P. G., Díaz‐García, F. J., Villaseñor‐Sierra, A., Segura, J., Carranza-Martínez, M. I., Arredondo-Garcı́a, J. L., & Santos, J. I. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00009-08 · Cited by 3
Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
McNamara, L. A., Pollard, A. J., & Harrison, L. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00039-6 · Cited by 4
HIV-1 Membrane-Proximal External Region Fused to Diphtheria Toxin Domain-A Elicits 4E10-Like Antibodies in Mice
Zhang, Z., Wei, X., Lin, Y., Huang, F., Shao, J., Qi, J., Deng, T., Li, Z., Gao, S., Li, S., et al. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.07.004 · Cited by 3
Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018
Koliou, M., Kasapi, D., Mazeri, S., Maikanti-Charalampous, P., Demetriou, A., Skordi, C., Agathocleous, M., Tzanakaki, G., & Constantinou, E. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.30.1900534 · Cited by 3
Enfermedad meningocócica invasiva por serogrupo C en la era posvacunal y fallos vacunales
Rius, N., Lung, M., José, C. F.-S., Iglesias, T., Esperalba, J., Llop, F. A. M., & Soler‐Palacín, P. (2020) · Anales de Pediatría · doi:10.1016/j.anpedi.2020.02.008 · Cited by 3
Chronic fatigue syndrome or myalgic encephalomyelitis
White, P. D., Murphy, M., Moss, J., Armstrong, G., & Spencer, S. P. (2007) · BMJ · doi:10.1136/bmj.39316.472361.80 · Cited by 3
Immunizations, neonatal jaundice, and animal-induced injuries
Morris, S. A., & Bernstein, H. H. (2004) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000133711.72529.78 · Cited by 3
Effect of the DTwP Haemophilus influenzae b Conjugate Vaccination in Mexico (1999–2007)
Cruces, P. G. D. L., García, J. D., & Santos, J. I. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.05.010 · Cited by 3
Evaluating Sistema Scotland
Harkins, C. (2014) · Cited by 3
Communicable diseases report, May and June 2005
Forssman, B. L., Gupta, L., Salmon, S., Fritsche, L. L., Irvine, K., & Moomer, M. (2005) · New South Wales Public Health Bulletin · doi:10.1071/nb05038 · Cited by 3
Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial
Tashani, M., Badahdah, A.-M. M., Alfelali, M., Barasheed, O., Alqahtani, A. S., Heron, L. G., Wong, M., Louth, J. C., Rashid, H., Borrow, R., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.05.025 · Cited by 3
Meningococemia fulminante
Álvaro, R., Micó, M., Madero, J., Costa, A., Montoya, E., & Roca, B. (2005) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(05)73069-6 · Cited by 3
MENINGOCOCCAL INFECTIONS
Anderson, M. S., Glodé, M. P., & Smith, A. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50104-7 · Cited by 3
Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories
(2010) · Canada Communicable Disease Report · doi:10.14745/ccdr.v36i00as2 · Cited by 3
Enfermedad meningocócica en España. Resultados de la vigilancia epidemiológica de la temporada 2004-2005
Jiménez‐Jorge, S., Simón, L., Hontoria, M. G., & Cano, R. (2012) · Boletín epidemiológico semanal: Vigilancia epidemiológica · Cited by 3
Les vaccins conjugués
Fritzell, B. (2005) · Therapies · doi:10.2515/therapie:2005032 · Cited by 3
Anticapsular Polysaccharide IgG Concentrations in Mexican Children Formerly Immunized with Haemophilus Influenzae b Prp-T Vaccine
de León, P. G., García, F. J. D., Arredondo-Garcı́a, J. L., Jorge, J., Cerezo, S. G., & Santos, J. I. (2007) · Human Vaccines · doi:10.4161/hv.3.5.4376 · Cited by 3
Focus: Meningococcal meningitis
Aguado, T., Bertherat, E., Djingarey, M. H., Kandolo, D., Kiény, M. P., Konde, K., LaForce, F. M., Nelson, C. B., Perea, W., & Preziosi, M.-P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1070 · Cited by 3
Purpura Fulminans without Meningitis: A Rare Condition?
de Souza, A. L., Andrade, L., & Seguro, A. C. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.032 · Cited by 3
Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2005
de Pediatría, C. A. D. V. D. L. A. E. (2005) · Vacunas · doi:10.1016/s1576-9887(05)73003-x · Cited by 3
Vaccines for International Travel
Barnett, E. D., Kozarsky, P. E., & Steffen, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00071-7 · Cited by 2
Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12–23 months in China
Hu, J., Li, H., Chu, K., Liang, Q., Li, J., Luo, L., Hu, Y., Meng, F., & Zhu, F. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1627816 · Cited by 2
The Future of Meningococcal Vaccines
Borrow, R., & Balmer, P. (2007) · Pediatric Health · doi:10.2217/17455111.1.1.51 · Cited by 2
Conjugate vaccine-induced immunological priming is not protective against acute meningococcal C infection
Spoulou, V. I., Moschou, C. K., Tzanakaki, G., & Theodoridou, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.024 · Cited by 2
Infections à méningocoques
Taha, M. (2012) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/s1166-8598(12)58119-6 · Cited by 2
Do Dose Numbers Matter?
Bettinger, J. A., Vanderkooi, O. G., Scheifele, D. W., Halperin, S. A., Kellner, J. D., Schryvers, A. B., Serres, G. D., & Alcantara, J. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001278 · Cited by 2
A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines Análise crítica das recomendações do uso das vacinas meningocócicas conjugadas
Sáfadi, M. A. P., Berezin, E. N., & Oselka, G. W. (2012) · Cited by 2
Meningococcal Disease
Marquez, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00088-1 · Cited by 2
Immunogenicity of meningococcal PorA antigens in OMV vaccines
Luijkx, T. A. (2006) · Utrecht University Repository (Utrecht University) · Cited by 2
Immunisation at the crossroads: 9th National Immunisation/1st Asia–Pacific Vaccine Preventable Diseases Conference
McIntyre, P. B., Kelly, H. A., & Mulholland, K. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06547.x · Cited by 2
Update on new vaccines and immunisation strategies
Bonhoeffer, J., & Heath, P. T. (2006) · Current Paediatrics · doi:10.1016/j.cupe.2005.12.001 · Cited by 2
Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
Wing, J. B., Smart, L. E., Borrow, R., Findlow, J., Findlow, H., Lees, A., Read, R. C., & Heath, A. W. (2012) · PLoS ONE · doi:10.1371/annotation/45ca0028-74a1-427d-ba95-3dbd2acc6b80 · Cited by 2
Análise e determinação de custos específicos e consequências econômico-sociais na incorporação da vacina contra meningite e doença meningocócica C conjugada na rotina do Programa Nacional de Imunização/PNI
Itria, A. (2011) · doi:10.11606/t.5.2011.tde-12012012-092948 · Cited by 2
La inmunización frente a Neisseria meningitidis serogrupo C con vacuna conjugada: siete años de experiencia
Navarro-Alonso, J.-A. (2006) · Hispana · Cited by 2
Studies of Neisseria musculi Type IV Pilus and Capsule Using the Natural Mouse Model of Colonization and Persistence
Ma, M. (2019) · UA Campus Repository (The University of Arizona) · Cited by 2
Immunizations, neonatal jaundice, and animal-induced injuries
Lee, M. S., & Bernstein, H. H. (2005) · Current Opinion in Pediatrics · doi:10.1097/00008480-200506000-00016 · Cited by 2
Meningococcal diseases: From genomes to vaccines
Serino, L., Bambini, S., Comanducci, M., Pizza, M., & Rappuoli, R. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.06.011 · Cited by 1
A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines.
Otto, R. B. D., Crane, D. T., & Bolgiano, B. (2007) · Europe PMC (PubMed Central) · Cited by 1
Cochrane review: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia
Conterno, L., Filho, C. S., Rüggeberg, J., & Heath, P. T. (2007) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.126 · Cited by 1
Neue Impfung gegen Meningokokken B
Tenenbaum, T., & Knuf, M. (2012) · Pädiatrie · doi:10.1007/s15014-012-0140-8 · Cited by 1
Prevention of meningococcal disease through vaccination
Pollard, A. J., Feavers, I. M., & Cohn, A. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-28119-3_7 · Cited by 1
Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination
Pérez–Breva, L., Abad, R., Martínez‐Beneito, M. A., Puig‐Barberà, J., Alemán-Sánchez, S., Talamante, N. M., Sastre-Cantón, M., Vázquez, J. A., & Díez‐Domingo, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.022 · Cited by 1
Evidence for Rise in Meningococcal Serogroup C Bactericidal Antibody Titers in the Absence of Booster Vaccination in Previously Vaccinated Children
Badahdah, A.-M. M., Khatami, A., Tashani, M., Rashid, H., & Booy, R. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001861 · Cited by 1
Bacterial Carbohydrate-Based Vaccines
Jones, C. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00119-7 · Cited by 1
Neisseria meningitidis
Pollard, A. J., Finn, A. H. R., Bijker, E. M., & Cohn, A. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00125-7 · Cited by 1
The Elimination of Group A Meningococcal Meningitis From Sub-Saharan Africa After the Introduction of a New Group A Meningococcal Conjugate Vaccine
LaForce, F. M., Djingarey, M. H., Bita, A., Jadhav, S. S., Kulkarni, P. S., Viviani, S., & Préziosi, M. P. (2025) · doi:10.1093/oso/9780197687420.003.0006 · Cited by 1
A routine infant schedule versus an older infant/toddler schedule forNeisseria meningitidisvaccination: what do experience and reason tell us?
BLACK, S. B., & Shinefield, H. R. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.124 · Cited by 2
Recommended vaccination in adolescent age
Maďar, R. (2016) · Pediatrie pro praxi · doi:10.36290/ped.2016.017 · Cited by 1
Impfstoffe gegen Meningokokken für das Kindesalter
Tenenbaum, T., Hellenbrand, W., & Schroten, H. (2019) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-018-0635-7 · Cited by 1
Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria
Grabmeier‐Pfistershammer, K., Holleis, K., Rosskopf, S., Steinberger, P., Touzeau‐Roemer, V., Poeppl, W., & Rieger, A. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01561-4 · Cited by 1
Enfermedad meningocócica invasiva por serogrupo C en la era posvacunal y fallos vacunales
Melián, A. M., Merino, Á. H., Ruíz-Contreras, J., & Ortega, M. J. C. (2020) · Anales de Pediatría · doi:10.1016/j.anpedi.2020.10.003 · Cited by 1

Authors: Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E.
Affiliations: Manchester Royal Infirmary (GB)
ORCID: Trotter, Caroline L
Andrews, Nick J
Miller, Elizabeth
Ramsay, Mary E
Venue: The Lancet
Publisher: Elsevier BV
Published: 2004-07
Volume: 364
Issue: 9431
Pages: 365-367
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(04)16725-1
OpenAlex: W2160879811
Cited by: 571
References: 5
Citations by year: 2026: 1 · 2025: 4 · 2024: 1 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 12 · 2019: 15 · 2018: 18 · 2017: 26 · 2016: 23 · 2015: 33 · 2014: 27 · 2013: 29 · 2012: 42
FWCI: 50.77
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Explore Bristol Research (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
Keywords: vaccine effectiveness, long-term vaccine effectiveness, herd immunity, catch-up vaccination, meningococcal disease incidence, vaccination schedule, England
MeSH terms: Adolescent, Adult, Age Factors, Child, Child, Preschool, England, Follow-Up Studies, Humans, Immunization Schedule, Immunization, Secondary, Infant, Meningococcal Infections, Vaccines, Conjugate, Meningococcal Vaccines, Immunity, Herd, Neisseria meningitidis, Serogroup C

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks